Stock listing

OTC:ENDV Endonovo Therapeutics, Inc. Stock

Follow Endonovo Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · OTC:ENDV

$0.0001 USD +0.0001

Close on Oct 30, 2026

Past year -50.0% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.0001 – $0.0001 USDOct 30, 2026
Volume
170,000 sharesOct 30, 2026
Market cap
$180,756 USDAt the close on Oct 30, 2026 · price × 1.81B shares outstanding
52-week range
$0.0001 – $0.0002 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$41 USDMedian day 21,250 shares · 17 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Endonovo Therapeutics, Inc. logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OTC:ENDV · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0001$0.0001$0.0001170,000
$0.00010.00000.0%$0.0001$0.0001$0.00011,010,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001100
$0.00010.00000.0%$0.0001$0.0001$0.00012,500
$0.00010.00000.0%$0.0001$0.0001$0.0001200,000
$0.00010.00000.0%$0.0001$0.0001$0.0001200
$0.00010.00000.0%$0.0001$0.0001$0.0001650,000
$0.00010.00000.0%$0.0001$0.0001$0.00011,010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000140,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001270,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00011,000,000
$0.00010.00000.0%—$0.0001—1,499,999
$0.00010.00000.0%$0.0001$0.0001$0.0001100
$0.00010.00000.0%$0.0001$0.0001$0.0001100
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001500,000
$0.00010.00000.0%$0.0001$0.0001$0.0001500,208
$0.00010.00000.0%$0.0001$0.0001$0.0001500,000
$0.00010.00000.0%—$0.0001—1,499,999
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001500,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%—$0.0001—1,499,999
$0.00010.00000.0%$0.0001$0.0001$0.0001999,999
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001500,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001500,000
$0.00010.00000.0%—$0.0001—1,599,999
$0.00010.00000.0%$0.0001$0.0001$0.0001500,000
$0.00010.00000.0%$0.0001$0.0001$0.0001500,000
$0.00010.00000.0%$0.0001$0.0001$0.00011,499,999
$0.00010.00000.0%$0.0001$0.0001$0.00011,999,999
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001999,999
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
Ticker
OTC:ENDV
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million

Dec 4, 2023

Endonovo's SofPulse® Secures Taiwan FDA Approval

Oct 12, 2023

Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution

Aug 22, 2023

Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update

Aug 8, 2023

New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.

Jun 22, 2023

Endonovo Pending Agreement to Develop Telehealth Division

Jun 7, 2023

Endonovo Launches SofPulse® into the Veterans Administration

May 2, 2023

Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies

Apr 25, 2023

Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman

Apr 13, 2023

Endonovo Announces Partnership with Santana Lead Singer Andy Vargas

Apr 10, 2023

All Endonovo Therapeutics, Inc. news

Decks

Endonovo Therapeutics, Inc. on 6ix

News releases
140 in all · newest Dec 4, 2023 · oldest 2015
Decks
1 deck · latest Mar 2, 2020

Log in to ask 6ix AI your own questions about Endonovo Therapeutics, Inc.